Fen1 mutations result in autoimmunity, chronic inflammation and cancers

L Zheng, H Dai, M Zhou, M Li, P Singh, J Qiu… - Nature medicine, 2007 - nature.com
Functional deficiency of the FEN1 gene has been suggested to cause genomic instability
and cancer predisposition. We have identified a group of FEN1 mutations in human cancer …

Overexpression and Hypomethylation of Flap Endonuclease 1 Gene in Breast and Other Cancers

P Singh, M Yang, H Dai, D Yu, Q Huang, W Tan… - Molecular Cancer …, 2008 - AACR
Abstract Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its
critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA …

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer

M Sato, L Girard, I Sekine, N Sunaga, RD Ramirez… - Oncogene, 2003 - nature.com
The underlying molecular mechanisms leading to microsatellite alteration and mutations in
human lung cancer remain unknown. Since Flap endonuclease1 (Fen1), which functions in …

Functional regulation of FEN1 nuclease and its link to cancer

L Zheng, J Jia, LD Finger, Z Guo, C Zer… - Nucleic acids …, 2011 - academic.oup.com
Abstract Flap endonuclease-1 (FEN1) is a member of the Rad2 structure-specific nuclease
family. FEN1 possesses FEN, 5′-exonuclease and gap-endonuclease activities. The …

Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding

Z Guo, L Zheng, H Xu, H Dai, M Zhou… - Nature chemical …, 2010 - nature.com
Abstract Flap endonuclease 1 (FEN1), a structure-specific endo-and exonuclease, has
multiple functions that determine essential biological processes, such as cell proliferation …

Flap endonuclease 1: a novel tumour suppresser protein

G Henneke, E Friedrich-Heineken… - Trends in biochemical …, 2003 - cell.com
Abstract Flap endonuclease 1 (Fen1) is a key enzyme for maintaining genetic stability in
eukaryotic genomes. Haploinsufficiency of Fen1 leads to the rapid progression of tumours in …

[HTML][HTML] An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development

DM van Pel, IJ Barrett, Y Shimizu, BV Sajesh… - PLoS …, 2013 - journals.plos.org
Harnessing genetic differences between cancerous and noncancerous cells offers a
strategy for the development of new therapies. Extrapolating from yeast genetic interaction …

Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner

JR Becker, D Gallo, W Leung, T Croissant… - Nucleic acids …, 2018 - academic.oup.com
Overexpression of the flap endonuclease FEN1 has been observed in a variety of cancer
types and is a marker for poor prognosis. To better understand the cellular consequences of …

FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination

E Guo, Y Ishii, J Mueller, A Srivatsan… - Proceedings of the …, 2020 - National Acad Sciences
Synthetic lethality strategies for cancer therapy exploit cancer-specific genetic defects to
identify targets that are uniquely essential to the survival of tumor cells. Here we show …

Vertebrate cells lacking FEN‐1 endonuclease are viable but hypersensitive to methylating agents and H2O2

Y Matsuzaki, N Adachi, H Koyama - Nucleic acids research, 2002 - academic.oup.com
The structure‐specific FEN‐1 endonuclease has been implicated in various cellular
processes, including DNA replication, repair and recombination. In vertebrate cells …